Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives.

ABSTRACT:

SUBMITTER: Malmberg R 

PROVIDER: S-EPMC11999877 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature